Handelsbanken Fonder Ab Rocket Pharmaceuticals, Inc. Transaction History
Handelsbanken Fonder Ab
- $24.3 Billion
- Q1 2025
A detailed history of Handelsbanken Fonder Ab transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 23,100 shares of RCKT stock, worth $67,221. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,100
Previous 23,100
-0.0%
Holding current value
$67,221
Previous $290,000
46.9%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
217Shares Held
97.1MCall Options Held
554KPut Options Held
446K-
Rtw Investments, LP New York, NY17.7MShares$51.5 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$24.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$17.8 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$14 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $220M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...